9 Provincial Alliance supplies negotiations are here!

Release date: 2020-01-07 Views: 0

Source: Cypress Blue Instruments  

Consumables 3 + 5, transformed into 3 + 6

9 provinces and cities join forces

On January 6, the Beijing-Tianjin-Hebei Medical Consumables Joint Procurement Platform released the "Notice on the Implementation of the Reporting of Historical Purchasing Data for the Joint Purchasing of Medical Consumables in Beijing-Tianjin-Hebei and Heiji-Liaomeng-Jinlu Medical Supplies (Artificial Crystals)" (hereinafter referred to as " Notice").

It is worth noting that the purchase of consumables is from 9 provinces and cities-Beijing, Tianjin, Hebei, Heilongjiang, Jilin, Liaoning, Inner Mongolia, Shanxi, and Shandong.

Compared with the 8 provinces and cities in the Tianjin Medical Insurance Bureau's previous news, Shandong Province has been added, and the scope of procurement and the affected enterprises have been further expanded.

In December 2019, the Tianjin Medical Insurance Bureau announced that the Beijing-Tianjin-Hebei joint procurement of medical consumables, as the nation's first inter-provincial regional procurement procurement alliance, was fully affirmed by the National Medical Insurance Bureau.

Liaoning, Jilin, Heilongjiang, Shanxi, Inner Mongolia and other places have also stated that they will actively follow up, participate in joint procurement, strive to establish a northern procurement alliance based on Beijing-Tianjin-Hebei cooperation, and form a new "3 + 5" joint procurement model.

Judging from this "Notice", a new model of "3 + 6" consumables joint procurement may have formed.

Large purchase volume, price drop will not be small

The "Notice" shows that in accordance with the requirements of the Beijing-Tianjin-Hebei and Heiji-Liaomeng-Jinlu Medicine Joint Procurement Offices, nine provinces (autonomous regions and municipalities) will be required to complete the historical procurement data of intraocular lens consumables.

The reporting units include nine public medical institutions in Beijing, Tianjin, Hebei, Heilongjiang, Jilin, Liaoning, Inner Mongolia, Shanxi, and Shandong.

Statistics and summary of the reporting units of all units of the company's intraocular lens ophthalmic consumable products in 2018 and 2019 corresponding to the purchase unit price (unit: yuan / piece) and the corresponding purchase quantity information (unit: piece), in Beijing-Tianjin-Hebei medical consumables joint Fill in data in the procurement platform.

The "Notice" also emphasized that all units must deeply understand the significance of the joint procurement of medical consumables in Beijing-Tianjin-Hebei and Heiji-Liao-Meng-Jin-Lu medical consumables, attach great importance to the reporting of historical procurement data, and appoint a person in charge.

It is understood that it was Anhui Province that negotiated the amount of IOL ophthalmic supplies.

On August 1, 2019, the website of the People's Government of Anhui Province announced that Anhui Province completed negotiations on the purchase price of two types of high-value consumables for ophthalmology (intraocular lenses), with an average price reduction of 18.1% for domestic products and an average price reduction of 20.9% for imported products. The overall average price reduction was 20.5%.

The price drop in Anhui Province is not large, but this time is different. It is the 9 provinces and cities that jointly negotiate with the quantity. The price and price correspond to each other. The larger the purchase volume, the more room for negotiation and price reduction.

According to the "Statistical Analysis Report on the Operation of the Pharmaceutical Circulation Industry in 2017" issued by the Ministry of Commerce, the total sales of medical devices in the nine provinces in 2017 were approximately 24.76 billion yuan, accounting for approximately 26.25% of the total national sales.

Approved by the National Medical Insurance Bureau and negotiated at the national level

According to the Tianjin Medical Insurance Bureau, the National Medical Insurance Bureau stated that it will continue to support the construction of procurement alliances with "Beijing-Tianjin-Hebei" as its core, adhere to the direction of "national organization, alliance procurement, and platform operations", and continuously improve the construction of the system and promote the alliance to Higher quality and higher level development.

The Tianjin Medical Insurance Bureau also stated that it will jointly organize the purchase of artificial lens ophthalmic consumables with relevant provincial and municipal medical insurance departments to effectively reduce the false high price.

In addition, under the guidance of the National Medical Insurance Bureau, a centralized procurement alliance for pharmaceutical and medical consumables in the northern region with Beijing, Tianjin and Hebei as the core will be gradually established.

Together with the relevant provincial and municipal medical insurance departments, we will jointly formulate a framework agreement for pharmaceutical procurement alliances in the northern region, improve procurement rules, and carry out centralized procurement of medical consumables.

Provincial alliances are expanding, and national supplies negotiations are not far off.

On December 5, 2019, the National Medical Insurance Bureau issued the "National Medical Security Administration's Reply to the Recommendation of the Second Session of the Thirteenth National People's Congress No. 1209", which indicated that the pilot work on the procurement of high-value consumables in China will be carried out.

The National Medical Insurance Bureau said that in the next step, the National Medical Insurance Bureau will select key varieties for pilot work with “quantity procurement” to reduce the price of high-value medical consumables and benefit the people.

In addition, the National Medical Insurance Bureau also stated in another reply that for exclusive products or patent-term products with high clinical value and high market prices, explore the establishment of a negotiation mechanism, and use medical insurance reimbursement as a lever to promote reasonable price formation.

Hunter QR code